Molecular diversity of sphingolipid signalling - PubMed (original) (raw)

Review

Molecular diversity of sphingolipid signalling

D Meyer zu Heringdorf et al. FEBS Lett. 1997.

Free article

Abstract

Sphingolipid breakdown products are now being recognized to play a dual role in cellular signalling, acting as intracellular as well as extracellular signalling molecules. Both types of action may even be found with one sphingolipid species. The recent demonstration of G protein-coupled receptors with high affinity for sphingosine 1-phosphate and sphingosylphosphorylcholine has been followed by the discovery of several novel sphingolipid actions, such as regulation of heart rate, oxidative burst, neurite retraction or platelet activation. Ligand profiles and concentration-response relationships suggest the existence of putative sphingolipid receptor subtypes. Against this background, several observations on supposed sphingolipid second messenger actions deserve a new evaluation.

PubMed Disclaimer

Similar articles

• Sphingosine-1-phosphate: an enigmatic signalling lipid.
  Spiegel S, Milstien S. Spiegel S, et al. Nat Rev Mol Cell Biol. 2003 May;4(5):397-407. doi: 10.1038/nrm1103. Nat Rev Mol Cell Biol. 2003. PMID: 12728273 Review.
• Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids.
  Hannun YA, Linardic CM. Hannun YA, et al. Biochim Biophys Acta. 1993 Dec 21;1154(3-4):223-36. doi: 10.1016/0304-4157(93)90001-5. Biochim Biophys Acta. 1993. PMID: 8280742 Review.
• Sphingosine-1-phosphate: signaling inside and out.
  Spiegel S, Milstien S. Spiegel S, et al. FEBS Lett. 2000 Jun 30;476(1-2):55-7. doi: 10.1016/s0014-5793(00)01670-7. FEBS Lett. 2000. PMID: 10878250 Review.
• A role for G protein-coupled lysophospholipid receptors in sphingolipid-induced Ca2+ signaling in MC3T3-E1 osteoblastic cells.
  Lyons JM, Karin NJ. Lyons JM, et al. J Bone Miner Res. 2001 Nov;16(11):2035-42. doi: 10.1359/jbmr.2001.16.11.2035. J Bone Miner Res. 2001. PMID: 11697799
• Metabolic depletion of sphingolipids impairs ligand binding and signaling of human serotonin1A receptors.
  Paila YD, Ganguly S, Chattopadhyay A. Paila YD, et al. Biochemistry. 2010 Mar 23;49(11):2389-97. doi: 10.1021/bi1001536. Biochemistry. 2010. PMID: 20170167

Cited by

• Re-evaluation of primary structure, topology, and localization of Scamper, a putative intracellular Ca2+ channel activated by sphingosylphosphocholine.
  Schnurbus R, de Pietri Tonelli D, Grohovaz F, Zacchetti D. Schnurbus R, et al. Biochem J. 2002 Feb 15;362(Pt 1):183-9. doi: 10.1042/0264-6021:3620183. Biochem J. 2002. PMID: 11829755 Free PMC article.
• Evidence for the presence of multiple forms of Sph kinase in human platelets.
  Banno Y, Kato M, Hara A, Nozawa Y. Banno Y, et al. Biochem J. 1998 Oct 15;335 ( Pt 2)(Pt 2):301-4. doi: 10.1042/bj3350301. Biochem J. 1998. PMID: 9761727 Free PMC article.
• Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro.
  Bischoff A, Czyborra P, Fetscher C, Meyer Zu Heringdorf D, Jakobs KH, Michel MC. Bischoff A, et al. Br J Pharmacol. 2000 Aug;130(8):1871-7. doi: 10.1038/sj.bjp.0703515. Br J Pharmacol. 2000. PMID: 10952677 Free PMC article.
• Sphingosine 1-phosphate enhances spontaneous transmitter release at the frog neuromuscular junction.
  Brailoiu E, Cooper RL, Dun NJ. Brailoiu E, et al. Br J Pharmacol. 2002 Aug;136(8):1093-7. doi: 10.1038/sj.bjp.0704839. Br J Pharmacol. 2002. PMID: 12163341 Free PMC article.
• Ceramides and other sphingolipids as predictors of incident dysglycemia (CASPID): Design, methods, and baseline characteristics.
  Mandal N, Asuzu P, Stentz F, Wan J, Dagogo-Jack S. Mandal N, et al. Exp Biol Med (Maywood). 2023 Aug;248(16):1393-1402. doi: 10.1177/15353702231184228. Epub 2023 Jul 15. Exp Biol Med (Maywood). 2023. PMID: 37452717 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database